Atomi Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Atomi Financial Group's BMY Position: Q1 2026 in Review
Atomi Financial Group increased its Bristol-Myers Squibb (BMY) stake by 245% in Q1 2026, buying an estimated $3.37M and bringing the position to 81,491 shares worth $4.94M. The position accounts for 0.15% of the portfolio, ranked #120.
Atomi Financial Group first reported a position in BMY in Q1 2024 and has held it in 8 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Atomi Financial Group held 81,491 shares of Bristol-Myers Squibb worth $4.94M as of Q1 2026.
- Atomi Financial Group bought 57,858 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.37M.
- Bristol-Myers Squibb made up 0.15% of Atomi Financial Group's portfolio in Q1 2026, its #120 holding.
- Atomi Financial Group first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 8 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.